Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v6-FR
Language French French
Date Updated 2023-01-31 2022-06-13
Drug Identification Number 02490625 02490625
Brand name JAMP METHIMAZOLE JAMP METHIMAZOLE
Common or Proper name Methimazole Tablets, USP Methimazole Tablets, USP
Company Name JAMP PHARMA CORPORATION JAMP PHARMA CORPORATION
Ingredients METHIMAZOLE METHIMAZOLE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code H03BB H03BB
ATC description ANTITHYROID PREPARATIONS ANTITHYROID PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-02-09 2022-02-09
Actual start date 2022-04-30 2022-04-30
Estimated end date 2023-02-10 2022-10-31
Actual end date 2023-01-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments